The promise of gene therapy in gastrointestinal and liver diseases. (1st May 2003)

• Record Type: Journal Article
• Authors: Prieto, J; Herraiz, M; Sangro, B; Qian, C; Mazzolini, G; Melero, I; Ruiz, J
• Is Part Of: Gut. Volume 52(2003)Supplement 2
• Page Start: ii49
• Page End: ii54
• Publication Date: 2003-05-01
• Subjects: gene therapy; AAV, adeno-associated viruses -- HSV, herpes simplex virus -- GI, gastrointestinal -- IL, interleukin -- IFN, interferon -- WHV, woodchuck hepatitis virus; Gastroenterology -- Periodicals; 616.33
• DOI: 10.1136/gut.52.suppl_2.ii49
• Languages: English
• ISSNs: 0017-5749

Abstract

Abstract : Gene therapy consists of the transfer of genetic material to cells to achieve a therapeutic goal. In the field of gastroenterology and hepatology gene therapy has produced considerable expectation as a potential tool in the management of conditions that lack effective therapy including non-resectable neoplasms of the liver, pancreas and gastrointestinal tract, chronic viral hepatitis unresponsive to interferon therapy, liver cirrhosis, and inflammatory bowel disease.